We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma (PANACHE01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02959879
Recruitment Status : Unknown
Verified April 2018 by University Hospital, Rouen.
Recruitment status was:  Recruiting
First Posted : November 9, 2016
Last Update Posted : April 26, 2018
Federation Francophone de Cancerologie Digestive
Federation of Research in Surgery (FRENCH)
GERCOR - Multidisciplinary Oncology Cooperative Group
Information provided by (Responsible Party):
University Hospital, Rouen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021